Anders Åhlin

2.9k total citations
37 papers, 2.2k citations indexed

About

Anders Åhlin is a scholar working on Immunology, Molecular Biology and Pharmacology. According to data from OpenAlex, Anders Åhlin has authored 37 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 13 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Anders Åhlin's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (17 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Complement system in diseases (5 papers). Anders Åhlin is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (17 papers), Cholinesterase and Neurodegenerative Diseases (5 papers) and Complement system in diseases (5 papers). Anders Åhlin collaborates with scholars based in Sweden, Netherlands and United States. Anders Åhlin's co-authors include Dirk Roos, Martin de Boer, Bengt Fadeel, Jan‐Inge Henter, Mark B. Hampton, Sten Orrenius, Ewa Bernatowska, Jan Palmblad, Weening Rs and Henrik Nybäck and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and PLoS ONE.

In The Last Decade

Anders Åhlin

33 papers receiving 2.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anders Åhlin 1.4k 745 289 284 281 37 2.2k
Pin‐Yu Perera 2.2k 1.6× 892 1.2× 148 0.5× 217 0.8× 550 2.0× 47 3.5k
Kris A. Steinbrecher 933 0.7× 1.0k 1.4× 338 1.2× 122 0.4× 334 1.2× 49 2.7k
Lori Zbytnuik 2.0k 1.5× 790 1.1× 294 1.0× 158 0.6× 305 1.1× 27 3.0k
Andrew C. Keates 1.1k 0.8× 736 1.0× 200 0.7× 431 1.5× 314 1.1× 37 2.7k
Shohko Tsunawaki 1.2k 0.8× 810 1.1× 128 0.4× 207 0.7× 224 0.8× 42 2.3k
Tieno Germann 2.1k 1.6× 590 0.8× 250 0.9× 206 0.7× 464 1.7× 44 3.8k
Ehud Zigmond 2.2k 1.6× 1.0k 1.4× 422 1.5× 186 0.7× 475 1.7× 41 3.7k
J L Madara 687 0.5× 777 1.0× 231 0.8× 159 0.6× 137 0.5× 18 2.0k
Kenneth C. Malcolm 1.1k 0.8× 1.3k 1.7× 139 0.5× 253 0.9× 419 1.5× 60 2.9k
C. Galanos 1.6k 1.2× 794 1.1× 131 0.5× 98 0.3× 313 1.1× 34 2.7k

Countries citing papers authored by Anders Åhlin

Since Specialization
Citations

This map shows the geographic impact of Anders Åhlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Åhlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Åhlin more than expected).

Fields of papers citing papers by Anders Åhlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Åhlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Åhlin. The network helps show where Anders Åhlin may publish in the future.

Co-authorship network of co-authors of Anders Åhlin

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Åhlin. A scholar is included among the top collaborators of Anders Åhlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Åhlin. Anders Åhlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsson, Fredrik, Anders Åhlin, Mats Heyman, & Jonas Abrahamsson. (2016). [Acute splenic sequestration in children with sickle cell disease--an overview].. PubMed. 113. 2 indexed citations
2.
Olsson, Richard F., et al.. (2015). Allogeneic haematopoietic stem cell transplantation in the treatment of human C1q deficiency. Molecular Immunology. 67(1). 168–168. 1 indexed citations
3.
Olsson, Richard F., et al.. (2015). Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Human C1q Deficiency. Transplantation. 100(6). 1356–1362. 26 indexed citations
4.
Åhlin, Anders & Anders Fasth. (2014). Chronic granulomatous disease – conventional treatment vs. hematopoietic stem cell transplantation. Current Opinion in Hematology. 22(1). 41–45. 30 indexed citations
5.
Schejbel, Lone, Lillemor Skattum, Stefan Hagelberg, et al.. (2011). Molecular basis of hereditary C1q deficiency—revisited: identification of several novel disease-causing mutations. Genes and Immunity. 12(8). 626–634. 74 indexed citations
6.
Åhlin, Anders, et al.. (2010). Nurses - psychiatrists' main collaborators when treating women with postpartum psychosis. Journal of Psychiatric and Mental Health Nursing. 17(6). 494–502. 8 indexed citations
7.
Berg, J. Merlijn van den, Anders Åhlin, Bernd H. Belohradsky, et al.. (2009). Chronic Granulomatous Disease: The European Experience. PLoS ONE. 4(4). e5234–e5234. 455 indexed citations
8.
Nybäck, Henrik, et al.. (2009). Clinical experiences and biochemical findings with tacrine (THA). Acta Neurologica Scandinavica. 88(S149). 36–38.
9.
Roos, Dirk, Martin de Boer, Mustafa Yavuz Köker, et al.. (2006). Chronic granulomatous disease caused by mutations other than the common GT deletion inNCF1, the gene encoding the p47phoxcomponent of the phagocyte NADPH oxidase. Human Mutation. 27(12). 1218–1229. 41 indexed citations
10.
Carlsson, Göran, Anders Åhlin, Göran Dahllöf, et al.. (2004). Efficacy and safety of two different rG‐CSF preparations in the treatment of patients with severe congenital neutropenia*. British Journal of Haematology. 126(1). 127–132. 28 indexed citations
11.
Palmblad, Jan, Anders Hansson, Mikael Heimbürger, & Anders Åhlin. (2004). Abberant Cytosolic Calcium Ion Mobilization in Chronic Granulomatous Disease Neutrophils. Inflammation. 28(3). 133–138. 1 indexed citations
12.
Meischl, Christof, Martin de Boer, Anders Åhlin, & Dirk Roos. (2000). A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. European Journal of Human Genetics. 8(9). 697–703. 87 indexed citations
13.
Leusen, Jeanette H.W., P. M. Hilarius, Anders Åhlin, et al.. (1996). Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease.. The Journal of Experimental Medicine. 184(4). 1243–1249. 70 indexed citations
14.
Roos, Dirk, Martin de Boer, Futoshi Kuribayashi, et al.. (1996). Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood. 87(5). 1663–1681. 345 indexed citations
15.
Åhlin, Anders, Martin de Boer, Dirk Roos, et al.. (1995). Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatrica. 84(12). 1386–1394. 80 indexed citations
16.
Nybäck, Henrik, Christer Halldin, Anders Åhlin, Margareta Curvall, & Lars I. Eriksson. (1994). PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo. Psychopharmacology. 115(1-2). 31–36. 84 indexed citations
17.
Rabbani, Hodjattallah, Martin de Boer, Anders Åhlin, et al.. (1993). A 40‐base‐pair duplication in the gp91‐phox gene leading to X‐linked chronic granulomatous disease. European Journal Of Haematology. 51(4). 218–222. 11 indexed citations
18.
Boer, Martin de, et al.. (1992). Splice site mutations are a common cause of X-linked chronic granulomatous disease. Blood. 80(6). 1553–1558. 46 indexed citations
19.
Åhlin, Anders, et al.. (1992). Pharmacokinetics of tetrahydroaminoacridine. International Clinical Psychopharmacology. 7(1). 29–36. 29 indexed citations
20.
Åhlin, Anders, et al.. (1991). Tetrahydroaminoacridine in Alzheimer's dementia: Clinical and biochemical results of a double‐blind crossover trial. Human Psychopharmacology Clinical and Experimental. 6(2). 109–118. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pin‐Yu Perera Breakdown of academic impact, for papers by Kris A. Steinbrecher Breakdown of academic impact, for papers by Lori Zbytnuik Breakdown of academic impact, for papers by Andrew C. Keates Breakdown of academic impact, for papers by Shohko Tsunawaki Breakdown of academic impact, for papers by Tieno Germann Breakdown of academic impact, for papers by Ehud Zigmond Breakdown of academic impact, for papers by J L Madara Breakdown of academic impact, for papers by Kenneth C. Malcolm Breakdown of academic impact, for papers by C. Galanos
Rankless by CCL
2026